- Home
- ELAB vs TOVX Comparison
ELAB vs TOVX Comparison
Compare ELAB & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELAB
- TOVX
- Stock Information
- Founded
- ELAB 2020
- TOVX 2001
- Country
- ELAB United States
- TOVX United States
- Employees
- ELAB N/A
- TOVX N/A
- Industry
- ELAB
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- ELAB
- TOVX Health Care
- Exchange
- ELAB Nasdaq
- TOVX Nasdaq
- Market Cap
- ELAB 3.2M
- TOVX 3.8M
- IPO Year
- ELAB 2023
- TOVX 2006
- Fundamental
- Price
- ELAB $9.61
- TOVX $0.43
- Analyst Decision
- ELAB
- TOVX Hold
- Analyst Count
- ELAB 0
- TOVX 1
- Target Price
- ELAB N/A
- TOVX N/A
- AVG Volume (30 Days)
- ELAB 128.7K
- TOVX 1.3M
- Earning Date
- ELAB 11-13-2025
- TOVX 11-11-2025
- Dividend Yield
- ELAB N/A
- TOVX N/A
- EPS Growth
- ELAB N/A
- TOVX N/A
- EPS
- ELAB N/A
- TOVX N/A
- Revenue
- ELAB N/A
- TOVX N/A
- Revenue This Year
- ELAB N/A
- TOVX N/A
- Revenue Next Year
- ELAB N/A
- TOVX N/A
- P/E Ratio
- ELAB N/A
- TOVX N/A
- Revenue Growth
- ELAB N/A
- TOVX N/A
- 52 Week Low
- ELAB $4.29
- TOVX $0.37
- 52 Week High
- ELAB $903.86
- TOVX $2.64
- Technical
- Relative Strength Index (RSI)
- ELAB 78.56
- TOVX 51.02
- Support Level
- ELAB $5.00
- TOVX $0.41
- Resistance Level
- ELAB $6.90
- TOVX $0.51
- Average True Range (ATR)
- ELAB 0.51
- TOVX 0.04
- MACD
- ELAB 0.15
- TOVX 0.01
- Stochastic Oscillator
- ELAB 96.39
- TOVX 33.51
About ELAB Elevai Labs Inc.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.